The CDCN’s Annual “Accelerating Research & Treatment for Castleman Disease,” Working Dinner helps to disseminate cutting edge Castleman disease research
The Castleman Disease Collaborative Network (CDCN) hosted the 12th Annual “Accelerating Research & Treatment for Castleman Disease,” working dinner in-person on December 10, 2023 at the annual American Society of Hematology Meeting in San Diego, California. The CDCN was delighted to have this event in-person. We were joined with fellow physicians and researchers from around the globe, who are dedicated to advancing the understanding and treatment of Castleman disease. The event discussed cutting edge research and important issues for patient care.
This event was co-sponsored by the CDCN and Recordati
Accepted abstracts are below.
| Castleman Disease Poster Presentations at ASH Saturday, December 9th |
|
| Michael Gonzalez 1993 |
Identification of Autoantibodies Associated with Connective Tissue Disorders in Idiopathic Multicentric Castleman Disease, Abstract Link, Poster Link |
| David Boutboul 2033 |
Multicentric Hyaline-Vascular Castleman Disease: The Missing Link?, Abstract Link |
| Karan Kanhai 1751 |
The Clinical Picture of Castleman Disease: A Systematic Review and Meta-Analysis of Almost 2000 Patients, Abstract Link, Poster Link |
| Castleman Disease Poster Presentations at ASH Sunday, December 10th |
|
| Eric Oksenhendler
3412 |
KSHV/HHV-8 Associated Multicentric Castleman Disease in 80 HIV Negative Patients, Abstract Link |
| Castleman Disease Poster Presentations at CDCN Working Dinner Sunday, December 10th |
|
| Chathuri Weerasinghe | Unicentric-mesenteric Castleman disease in a child: an unusual presentation, Abstract Link, Poster Link |
| Takuya Harada | Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease, Abstract Link, Poster Link |
| Marta Pereira | Regression of porto-pulmonary hypertension in an iMCD patient under siltuximab, Abstract Link, Poster Link |
| David Shia | Lymphadenopathy in the time of Kaposi’s and a tale of two cytopenias, Abstract Link, Poster Link |
| Kelly Makarounas-Kirchmann | Symptom burden in patients with idiopathic multicentric Castleman disease and its impact on daily life: an international patient and caregiver study, Abstract Link, Poster Link |
| Kelly Makarounas-Kirchmann | An exploratory internal psychometric validation of a burden of illness international survey for idiopathic multicentric Castleman disease, Abstract Link, Poster Link |
| Kelly Makarounas-Kirchmann | Producting a novel idiopathic multicentric Castleman disease symptom burden scale (ISBUS), Abstract Link, Poster Link |
| Castleman Disease Oral Presentations at ASH Monday, December 11th |
|
| Aaron Cohen
907 |
Clinical Characteristics, Treatment Trends, and Outcomes of Patients with HHV-8-Negative/Idiopathic Multicentric Castleman Disease Treated with Siltuximab in a Machine Learning-Selected Real-World Cohort, Presentation Link |
| Castleman Disease Poster Presentations at ASH Monday, December 11th |
|
| Saishravan Shyamsundar
4415 |
Clinical Characteristics and Treatment Outcomes of Idiopathic Multicentric Castleman Disease: Data from a Pediatric Cohort, Abstract Link, Poster Link |
| Ira Miller
4402 |
Exploratory Analyses of Lymph Node Tissue, Serum, and Peripheral Blood Mononuclear Cells Do Not Reveal Pathogen Signatures in Idiopathic Multicentric Castleman Disease, Abstract Link, Poster Link |
| Melanie Mumau
3921 |
A Translational Approach to Identifying and Targeting TNF Signaling in Idiopathic Multicentric Castleman Disease, Abstract Link, Poster Link |
| Dorottya Laczko
3920 |
The Role of CABIN1 in the Pathogenesis of Idiopathic Multicentric Castleman Disease, Abstract Link |
This annual meeting is tremendous example of the power of the CDCN’s collaborative research approach to defeating Castleman disease.
The last in-person CDCN Annual “Accelerating Research & Treatment for Castleman Disease,” Working Dinner was held during the 2022 ASH Meeting in New Orleans, Lousiana. Research related to Castleman disease was showcased at the Working Dinner.